CannTrust Holdings Incorporated (TSX:TRST)(NYSE:CTST), a federally licensed provider of medical cannabis, has named Greg Guyatt as its new chief executive officer, it was reported on Thursday.
Guyatt is the firm's present chief financial officer and will replace interim CEO, Robert Marcovitch.
Guyatt joined CannTrust in February 2019 as chief financial officer and is a Chartered Professional Accountant. He earlier served as the CFO of GreenSpace Brands Inc and has around 25 years of experience leading finance teams from the consumer packaged goods, pharmaceutical, and private equity sectors.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business